férfias Claire Pakisztán standard disease modifying antirheumatic drugs overall treatment labda Tart állandóan
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Conventional disease‐modifying antirheumatic drugs to treat rheumatoid arthritis - Rath - 2011 - Drug Development Research - Wiley Online Library
Rheumatoid Arthritis: Aggressive New Treatment Guidelines
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis | Annals of the Rheumatic Diseases
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea | Rheumatology and Therapy
LIST OF DMARDS USED TO TREAT RHEUMATOID ARTHRITIS | Download Table
The Korean Journal of Internal Medicine
DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
The Safety of Antirheumatic Drugs (11.02.2022)
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
Biologic DMARDs and targeted synthetic DMARDs approved for the... | Download Scientific Diagram
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan | springermedizin.de
Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
JCM | Free Full-Text | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy